110390 ⎘
Reverse transcribing RNA viruses; Details; Retroviridae; Lentivirus, not HIV, e.g. FIV, SIV Demonstrated effect
CD33 TARGETED IMMUNOTHERAPIES
#2COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY TARGETING FLT3, PD-1, AND/OR PD-L1
#3GENE THERAPY BASED ADMINISTRATION OF LENTIVIRUS VECTOR FOR TREATING HEMOGLOBINOPATHIES
#4RETARGETED RETROVIRAL VECTORS AND COMPOSITIONS OR METHODS OF USE THEREOF
#5VECTORED PROPHYLAXIS OF SARS-COV-2
#6COMPOSITIONS AND METHODS FOR USING ALTERNATIVE SPLICING TO CONTROL SPECIFICITY OF GENE THERAPY
#7TRANSIENT EXPRESSION SYSTEM FOR RNA
#8COMBINATION TREATMENT
#9LENTIVIRAL VECTORS ENABLING ROUTING ANTIGENS TO MHC-II PATHWAY AND INDUCING CD4+ AND CD8+ T-CELL RESPONSES IN A HOST
#10METHODS TO RE-ENGAGE A FETAL WOUND HEALING PATHWAY FOR ADULT SKIN REPAIR
#11COMPOSITIONS AND METHODS FOR TARGETING TUMOR ASSOCIATED TRANSCRIPTION FACTORS
#12COMPOSITIONS AND METHODS FOR IN VIVO GENERATION OF CAR EXPRESSING CELLS
#13OVEREXPRESSION OF LEMD2, LEMD3, OR CHMP7 AS A THERAPEUTIC MODALITY FOR TAUOPATHY
#14FUSOGENIC RHABDOVIRUS GLYCOPROTEINS AND USES THEREOF
#15NIPAH VIRUS ENVELOPE PSEUDOTYPED LENTIVIRUSES AND METHODS OF THEIR USE
#16IMMUNE CELLS OVEREXPRESSING CELL SIGNALING REGULATORY FACTOR INTRODUCED FROM OUTSIDE AND USE THEREOF
#17PERSISTENT MEMORY T-CELL RESPONSES TO CANCER AND INFECTIOUS-DISEASE ANTIGENS BY MANIPULATION OF AMINO ACID-CATABOLISM PATHWAYS
#18METHOD FOR TREATING MUSCULAR DYSTROPHY BY TARGETING LAMA1 GENE
#19VIRAL DELIVERY OF GAS VESICLE GENES
#20METHOD FOR IDENTIFYING REGULATORY ELEMENTS CONFORMATIONALLY
#21GROWTH FACTOR RESTORATION
#22CD24-ASSOCIATED PARTICLES AND RELATED METHODS AND USES THEREOF
#23CD33 TARGETED IMMUNOTHERAPIES
#24VECTORS AND COMPOSITIONS FOR TREATING HEMOGLOBINOPATHIES
#25IL-10-CONTAINING VACCINES AND USES THEREOF
#26COMPOSITIONS AND METHODS FOR TREATMENT OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
#27VIRAL VECTOR FOR TREATING AUTOIMMUNE DISEASE AND DIABETES AND CONSTRUCTION METHOD AND APPLICATION THEREOF
#28MICROVESICLE AND METHOD FOR PRODUCING THE SAME
#29Rev-dependent lentiviral vaccine particles for reducing viral rebound and viral reservoirs in vivo
#30Glaucoma treatment
#31Vectors and compositions for treating hemoglobinopathies
#32IL-12 IMMUNOTHERAPY FOR CANCER
#33METHOD FOR AUGMENTING VISION IN PERSONS SUFFERING FROM PHOTORECEPTOR CELL DEGENERATION
#34Transgenic VERO-CD4/CCR5 cell line
#35CMV glycoproteins and recombinant vectors
#36GENE THERAPY FOR PATIENTS WITH FANCONI ANEMIA
#37Nipah virus envelope pseudotyped lentiviruses and methods of their use
#38METHOD FOR PREPARING VIRAL PARTICLES WITH CYCLIC DINUCLEOTIDE AND USE OF SAID PARTICLES FOR TREATING CANCER
#39LIGHT-ACTIVATED CATION CHANNEL AND USES THEREOF
#40Cross-reactive T-cell epitopes of HIV, SIV, and FIV for vaccines in humans and cats
#41Light-activated cation channel and uses thereof
#42Nipah virus envelope pseudotyped lentiviruses and methods of their use
#43Transgenic Vero-CD4/CCR5 cell line
#44Replication-competent VSV-HIV Env vaccines
#45Light-activated cation channel and uses thereof
#46COMPOSITIONS AND METHODS FOR CANCER TREATMENT
#47Compositions and methods comprising hydrocarbon-stapled polypeptides
#48Compositions and methods for treatment of cancer
#49Compositions and methods for treatment of cancer
#50IL-12 immunotherapy for cancer
#51Systemic and local ex vivo gene therapy of the skeleton
#52Implantable prosthetic device comprising a cell expressing a channelrhodopsin
#53Replication-competent adenoviral vectors
#54MICROVESICLE AND METHOD FOR PRODUCING THE SAME
#55IMMUNOTHERAPY OF CANCER THROUGH COMBINATION OF LOCAL AND SYSTEMIC IMMUNE STIMULATION
#56Method for augmenting vision in persons suffering from photoreceptor cell degeneration
#57Glaucoma treatment
#58METHOD AND COMPOSITION FOR TREATING SPASTICITY
#59Elimination of immune responses to viral vectors
#60Light-activated cation channel and uses thereof
#61CMV glycoproteins and recombinant vectors
#62Light-activated cation channel and uses thereof
#63TREATMENT REGIMEN FOR PARKINSON'S DISEASE
#64Compositions and methods for the treatment of viral infections
#65Vaccine
#66Method for production of pluripotent stem cell
#67Elimination of immune responses to viral vectors
#68Compositions and Methods for Cancer Treatment
#69IL-12 immunotherapy for cancer
#70Delivery of a light-activated cation channel into the brain of a subject
#71Light-activated cation channel and uses thereof
#72Light-activated cation channel and uses thereof
#73LIGHT-ACTIVATED CATION CHANNEL AND USES THEREOF
#74Treatment of pain through expression of opioid receptors
#75Therapeutic immunization of hiv-infected individuals
#76Replication-competent adenoviral vectors
#77Method for augmenting vision in persons suffering from photoreceptor cell degeneration
#78Specific chimeric antigen receptor cells targeting human CLDN18A2, preparation method and application thereof